Uncategorized
Bitcoin, Ethereum, Dogecoin Drop As Geopolitical Tensions Escalate
The cryptocurrency market pulled back Tuesday morning, driven by heightened geopolitical concerns following Trump’s evacuation warning regarding the Iran-Israel conflict. read more
4 Analysts Assess Riot Platforms: What You Need To Know
Latest Ratings for RIOT Date Firm Action From To Mar 2022 Compass Point Downgrades Buy Neutral Jan 2022 Northland Capital Markets Initiates Coverage On Outperform Jan 2022 Cantor Fitzgerald Initiates Coverage On Overweight View More Analyst Ratings for RIOT View the Latest Analyst Ratings read more
Beyond The Numbers: 5 Analysts Discuss Cooper Companies Stock
Latest Ratings for COO Date Firm Action From To Mar 2022 Stephens & Co. Maintains Overweight Jan 2022 Guggenheim Upgrades Neutral Buy Dec 2021 Keybanc Maintains Overweight View More Analyst Ratings for COO View the Latest Analyst Ratings read more
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Latest Ratings for ALKS Date Firm Action From To Jan 2022 Cantor Fitzgerald Upgrades Neutral Overweight Dec 2021 Citigroup Initiates Coverage On Neutral Nov 2021 SVB Leerink Maintains Market Perform View More Analyst Ratings for ALKS View the Latest Analyst Ratings read more
Nike Stock: A Deep Dive Into Analyst Perspectives (24 Ratings)
Latest Ratings for NKE Date Firm Action From To Mar 2022 Cowen & Co. Maintains Outperform Jan 2022 Wells Fargo Upgrades Equal-Weight Overweight Jan 2022 Seaport Global Initiates Coverage On Buy View More Analyst Ratings for NKE View the Latest Analyst Ratings read more
What 5 Analyst Ratings Have To Say About Millicom Intl Cellular
Latest Ratings for TIGO Date Firm Action From To Mar 2022 Scotiabank Upgrades Sector Perform Sector Outperform Nov 2021 New Street Research Upgrades Neutral Buy May 2021 Scotiabank Downgrades Outperform Sector Perform View More Analyst Ratings for TIGO View the Latest Analyst Ratings read more
Where BioLine Rx Stands With Analysts
Latest Ratings for BLRX Date Firm Action From To Feb 2021 HC Wainwright & Co. Maintains Buy Dec 2020 HC Wainwright & Co. Maintains Buy Aug 2017 Oppenheimer Initiates Coverage On Outperform View More Analyst Ratings for BLRX View the Latest Analyst Ratings read more
The Analyst Verdict: SolarEdge Technologies In The Eyes Of 15 Experts
Latest Ratings for SEDG Date Firm Action From To Mar 2022 B of A Securities Maintains Buy Feb 2022 Northland Capital Markets Maintains Underperform Feb 2022 Citigroup Maintains Buy View More Analyst Ratings for SEDG View the Latest Analyst Ratings read more
Hinge Health’s Tech Is Primed To Capture America’s Untapped MSK Pain Market: Analyst
Analysts initiate coverage of Hinge Health with Buy ratings, citing strong tech, recurring revenue, and a growing $18.5 billion MSK care market. read more